Adenosine improves post-procedural coronary flow but not clinical outcomes in patients with acute coronary syndrome: A meta-analysis of randomized trials

Atherosclerosis

Volumn 222, Issue 1, 2012, Pages 1-7

  Navarese, Eliano Pio ^a,d   Buffon, Antonino ^b   Andreotti, Felicita ^b   Gurbel, Paul Alfred ^c   Kozinski, Marek ^a   Kubica, Aldona ^d   Musumeci, Giuseppe ^e   Cremonesi, Alberto ^a   Tavazzi, Luigi ^a   Kubica, Jacek ^d   Castriota, Fausto ^a  

^a GVM Care Research   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c SINAI CENTER FOR THROMBOSIS RESEARCH   (United States)

^d NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^e OSPEDALI RIUNITI   (Italy)

Author keywords

Acute coronary syndrome; Adenosine; Clinical outcome

Indexed keywords

ADENOSINE; PLACEBO;

ACUTE CORONARY SYNDROME; BLOOD CLOT LYSIS; CARDIAC PATIENT; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFICACY; FOLLOW UP; HEART FAILURE; HEART REINFARCTION; HUMAN; META ANALYSIS; MORTALITY; NO REFLOW PHENOMENON; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ST SEGMENT;

ACUTE CORONARY SYNDROME; ADENOSINE; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; HEART FAILURE; HUMANS; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 84859812693     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.11.001     Document Type: Review

References (26)

1. Butler M.J., Chan W., Taylor A.J., Dart A.M., Duffy S.J. Management of the no-reflow phenomenon. Pharmacol Ther 2011, 132:72-85.
2. Claeys M.J., Bosmans J., De Ceuninck M., et al. Effect of intracoronary adenosine infusion during coronary intervention on myocardial reperfusion injury in patients with acute myocardial infarction. Am J Cardiol 2004, 94:9-13.
3. Stoel M.G., Marques K.M., de Cock C.C., et al. High dose adenosine for suboptimal myocardial reperfusion after primary PCI: a randomized placebo-controlled pilot study. Catheter Cardiovasc Interv 2008, 71:283-289.
4. The Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions. Available at: (accessed 24.08.11). http://www.cochrane.org/resources/handbook/.
5. Liberati A., Altman D.G., Tetzlaff J., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009, 339:b2700.
6. Fleiss J.L. Analysis of data from multiclinics trials. Controlled Clin Trials 1986, 7:267-275.
7. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
8. Egger M., Smith G.D., Schneider M., Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
9. Egger M., Smith G.D. Bias in location and selection of studies. BMJ 1998, 31:61-66.
10. Mahaffey K.W., Puma J.A., Barbagelata N.A., et al. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) Trial. J Am Coll Cardiol 1999, 34:1711-1720.
11. Ross A.M., Gibbons R.J., Stone G.W., et al. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol 2005, 45:1775-1780.
12. Quintana M., Hjemdahl P., Sollevi A., et al. Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis, results of the ATTenuation by Adenosine of Cardiac Complications (ATTACC) study. Eur J Clin Pharmacol 2003, 59:1-9.
13. Desmet W., Bogaert J., Dubois C., et al. High-dose intracoronary adenosine for myocardial salvage in patients with acute ST-segment elevation myocardial infarction. Eur Heart J 2011, 32:867-877.
14. Fokkema M.L., Vlaar P.J., Vogelzang M., et al. Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction: a randomized controlled trial. Circ Cardiovasc Interv 2009, 2:323-329.
15. Grygier M., Araszkiewicz A., Lesiak M., et al. New method of intracoronary adenosine injection to prevent microvascular reperfusion injury in patients with acute myocardial infarction undergoing percutaneous coronary intervention. Am J Cardiol 2011, 107:1131-1135.
16. Marzilli M., Orsini E., Marraccini P., Testa R. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation 2000, 101:2154-2159.
17. Tian F., Chen Y.D., Lü S.Z., et al. Intracoronary adenosine improves myocardial perfusion in late reperfused myocardial infarction. Chin Med J 2008, 121:195-199.
18. Vijayalakshmi K., Whittaker V.J., Kunadian B., et al. Prospective, randomised, controlled trial to study the effect of intracoronary injection of verapamil and adenosine on coronary blood flow during percutaneous coronary intervention in patients with acute coronary syndromes. Heart 2006, 92:1278-1284.
19. Babbitt D.G., Virmani R., Forman M.B. Intracoronary adenosine administered after reperfusion limits vascular injury after prolonged ischemia in the canine model. Circulation 1989, 80:1388-1399.
20. Velasco C.E., Turner M., Cobb M.A., Virmani R., Forman M.B. Myocardial reperfusion injury in the canine model after 40min of ischemia: effect of intracoronary adenosine. Am Heart J 1991, 122:1561-1570.
21. Teng B., Mustafa S.J. A(2A) adenosine receptor-mediated increase in coronary flow in hyperlipidemic APOE-knockout mice. J Exp Pharmacol 2011, 2011:59-68.
22. Andreotti F., Pasceri V. Ischaemic preconditioning. Lancet 1996, 348:204.
23. Van de Werf F., Bax J.J., Betriu A., et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Eur Heart J 2008, 29:2909-2945.
24. Assali A.R., Sdringola S., Ghani M., et al. Intracoronary adenosine administered during percutaneous intervention in acute myocardial infarction and reduction in the incidence of no reflow phenomenon. Catheter Cardiovasc Interv 2000, 51:27-31.
25. Shryock J.C., Belardinelli L. Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am J Cardiol 1997, 79:2-10.
26. Forman M.B., Stone G.W., Jackson E.K. Role of adenosine as adjunctive therapy in acute myocardial infarction. Cardiovasc Drug Rev 2006, 24:116-147.